TY - JOUR
T1 - Activity of pegylated liposomal doxorubicin for extragenital mullerian adenosarcoma with sarcomatous overgrowth
T2 - A case report and a review of the literature
AU - Maeda, M.
AU - Mabuchi, S.
AU - Matsumoto, Y.
AU - Hisamatsu, T.
AU - Ohashi, H.
AU - Kimura, T.
PY - 2011
Y1 - 2011
N2 - A 47-year-old woman was diagnosed with extragenital mullerian adenosarcoma with sarcomatous overgrowth. One month after her initial surgery, the patient developed pelvic recurrence, which was completely excised by surgery. However, one month later, the patient developed further recurrences in her pelvis and upper abdomen. A clinical complete response was achieved with three cycles of liposomal doxorubicin and is currently clinically free of disease. So far, including the present case, 23 cases of extragenital mulleian adenosarcoma have been reported in the English literature. Because of the rarity of the reported cases, there are no treatment guidelines based on a good level of evidence. In the current report, through a literature review, we provide information on the activity of pegylated liposomal doxorubicin for extragenital mullerian adenosarcoma with sarcomatous overgrowth.
AB - A 47-year-old woman was diagnosed with extragenital mullerian adenosarcoma with sarcomatous overgrowth. One month after her initial surgery, the patient developed pelvic recurrence, which was completely excised by surgery. However, one month later, the patient developed further recurrences in her pelvis and upper abdomen. A clinical complete response was achieved with three cycles of liposomal doxorubicin and is currently clinically free of disease. So far, including the present case, 23 cases of extragenital mulleian adenosarcoma have been reported in the English literature. Because of the rarity of the reported cases, there are no treatment guidelines based on a good level of evidence. In the current report, through a literature review, we provide information on the activity of pegylated liposomal doxorubicin for extragenital mullerian adenosarcoma with sarcomatous overgrowth.
KW - Endometriosis
KW - Extragenital adenosarcoma
KW - Liposomal doxorubicin
KW - Sarcomatous overgrowth
UR - http://www.scopus.com/inward/record.url?scp=81255154120&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=81255154120&partnerID=8YFLogxK
M3 - Article
C2 - 22053671
AN - SCOPUS:81255154120
SN - 0392-2936
VL - 32
SP - 542
EP - 546
JO - European journal of gynaecological oncology
JF - European journal of gynaecological oncology
IS - 5
ER -